Athyrium Opportunities Associates Co-Invest LLC — SEC Form 4 filings
SEC reporting owner CIK 1815259. 4 Form 4 filings on record with FilingPulse; latest filed 2024-12-16.
Transaction summary — filings shown
Covers all 4 filings on record, filed 2024-07-05 to 2024-12-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIORA THERAPEUTICS, INC. (BIOR) | Director, 10% owner | 4 | — | — | 15 |
Form 4 filings — Athyrium Opportunities Associates Co-Invest LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-12-16 | 4 | BIORA THERAPEUTICS, INC. (BIOR) jointly with Athyrium Opportunities III Co-Invest 1 LP, Athyrium Opportunities III Acquisition LP, Athyrium Opportunities III Acquisition 2 LP, Athyrium Opportunities 2020 LP, Ferrell Jeffrey, Athyrium Funds GP Holdings LLC, Athyrium Opportunities Associates III LP, Athyrium Opportunities Associates III GP LLC | Grant/award (A) | EDGAR |
| 2024-08-14 | 4 | BIORA THERAPEUTICS, INC. (BIOR) jointly with Athyrium Opportunities III Co-Invest 1 LP, Athyrium Opportunities III Acquisition LP, Athyrium Opportunities III Acquisition 2 LP, Athyrium Opportunities 2020 LP, Ferrell Jeffrey, Athyrium Funds GP Holdings LLC, Athyrium Opportunities Associates III LP, Athyrium Opportunities Associates III GP LLC | Disposition to issuer (D) · Grant/award (A) · Disposition to issuer (D): 323,886 (derivative) · Grant/award (A): 323,886 (derivative) · Disposition to issuer (D): 500,249 (derivative) · Grant/award (A): 500,249 (derivative) · +6 more | EDGAR |
| 2024-07-08 | 4 | BIORA THERAPEUTICS, INC. (BIOR) jointly with Athyrium Opportunities III Co-Invest 1 LP, Athyrium Opportunities III Acquisition LP, Athyrium Opportunities III Acquisition 2 LP, Athyrium Opportunities 2020 LP, Ferrell Jeffrey, Athyrium Funds GP Holdings LLC, Athyrium Opportunities Associates III LP, Athyrium Opportunities Associates III GP LLC | Grant/award (A): 457,250 (derivative) | EDGAR |
| 2024-07-05 | 4 | BIORA THERAPEUTICS, INC. (BIOR) jointly with Athyrium Opportunities III Co-Invest 1 LP, Athyrium Opportunities III Acquisition LP, Athyrium Opportunities III Acquisition 2 LP, Athyrium Opportunities 2020 LP, Ferrell Jeffrey, Athyrium Funds GP Holdings LLC, Athyrium Opportunities Associates III LP, Athyrium Opportunities Associates III GP LLC | Grant/award (A) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1815259 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →